#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ventricular fibrillation Immunoglobulin G4 related disease Chronic kidney disease Enteritis Hyperchylomicronaemia Deafness bilateral Activated PI3 kinase delta syndrome Autoimmune haemolytic anaemia Arginase deficiency Nephropathy Precursor T-lymphoblastic lymphoma/leukaemia recurrent Hydrocephalus Chronic cutaneous lupus erythematosus Urea cycle disorder Squamous cell carcinoma of the cervix More trials…

    Learn about Rare Diseases

    Angiosarcoma – Treatment Antisynthetase syndrome – Life with Disease Lennox-Gastaut syndrome – Diagnostics Angiosarcoma – Trials in Disease Hairy cell leukaemia – Treatment Acute respiratory distress syndrome – Basic Information Hepatic angiosarcoma – Life with Disease Medulloblastoma Skin angiosarcoma – Life with Disease VEXAS syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexlansoprazole Goserelin Siponimod Bevacizumab Zirconium Zr-89 NORELGESTROMIN Fluvastatin Sodium GSKVX000000070965 Thiocolchicoside Mercaptamine Paracetamol Ph. Eur. Spesolimab ATUMELNANT Isatuximab Etrasimod Arginine Bms-986442 Fosfomycin Trometamol Quercetin Tryptophan Etavopivat Panobinostat More therapies…

    Learn about Your Condition

    Laryngeal leukoplakia Multiple system atrophy Orthostatic hypotension Toxic epidermal necrolysis VEXAS syndrome Clinically isolated syndrome Lysosomal storage disorder Cutaneous calcification Renal cancer Encephalitis autoimmune Renal disorder Thrombectomy Menopause Bone hypertrophy Neurofibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • 3-[(3R)-3-[1-[5-Chloro-4-[[(1R)-1-(2,4-Dichlorophenyl)Ethyl]Amino]-6-Methylpyrimidin-2-Yl]Azetidin-3-Yl]Piperidin-1-Yl]-1-Methylcyclobutane-1-Carboxylic Acid
    • Salmeterol
    • Fluticasone Propionate
    Bulgaria Czechia Poland

  • Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tanimilast
    Bulgaria Czechia Germany Hungary Italy Latvia +4

  • Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    • Salbutamol
    Bulgaria Czechia Germany Greece Hungary Italy +5

  • Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Wheezing
    • Asthma
    Investigated Drugs:
    • Fluticasone
    • Ipratropium Bromide
    • Salmeterol
    Czechia France Germany Greece Hungary Italy +3

  • Study on Asthma Control and Adherence with Mepolizumab in Pre-filled Devices for Patients with Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Fluticasone Furoate
    • Indacaterol
    France

  • Study on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Benralizumab
    France Germany Italy Poland Spain
Previous Page
1 … 11 12 13 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!